Paradeep Phosph.Q1 FY27
Paradeep Phosph. Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹160P/E: 14.2Market Cap: ₹15.4K CrSector: Fertilizers & Agrochemicals
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Company expects higher traded volumes going forward, significantly above last year, aiding volume growth without pressuring EBITDA per ton due to supply chain efficiencies (Page 17).
- →Total fertilizer sales volume grew 13% YoY despite flat industry volume, driven by balanced market presence across India and strong brand development (Page 11).
- →Focus on increasing NPK adoption driven by farmer awareness on soil health and balanced nutrition, though short-term price caps on DAP affect portfolio mix; long-term balanced portfolio expected post price normalization (Page 17).
- →Capacity expansions underway: phosphoric acid capacity to increase from 5 to 7 lakh tons by FY27 end (December), granulation capacity expansion from 3.7 to 4 lakh tons expected by December (Page 16, 11).
- →Company aims to maintain sustainable EBITDA of around Rs.5,000 per ton, improving post expansion projects (Page 11, 16).
- →Robust import pipeline of ~0.5 million tons secured for rabi season to supplement demand (Page 13).
Margin guidance
Category 3- →Paradeep Phosphates Limited expects sustainable EBITDA of around Rs.5,000 per ton by the end of FY27, supported by supply chain efficiencies and backward integration (Pages 7, 14, 17).
- →Post completion of expansion projects, EBITDA per ton is targeted to improve by 30-35%, potentially reaching Rs.7,000+ per ton in 2 to 2.5 years, around FY29-30 (Pages 7, 14).
- →Phosphoric acid capacity expansion from 5 to 7 lakh tons is on track, with incremental capacity expected by December FY27, supporting volume growth (Pages 3, 7, 14).
- →The company anticipates volume growth driven by a balanced mix of manufactured and traded products, with traded volumes significantly higher than last year (Pages 13, 17).
- →Aluminium fluoride plant commissioning within 22-24 months is expected to add Rs.50 crore EBITDA, supporting diversification and non-subsidy revenue growth (Pages 3, 8).
- →Long-term vision to achieve at least 20% of EBITDA from non-subsidized businesses like industrial chemicals (Page 8).
3 more insights locked — sign up free to unlock
Fundraise plans
- →There is no explicit mention of any current or planned new fundraising through debt or equity in the call transcript.
- →Management discussed reducing overall debt from around Rs. 700 crores and positive operating cash flows, indicating a focus on deleveraging rather than raising new debt.
- →Capex expansions are planned and underway (e.g., phosphoric acid capacity increase, aluminium fluoride plant), but funding details (whether through debt or equity) were not disclosed.
- →Management mentioned sustainable EBITDA targets and optimizing working capital, suggesting internal cash generation is a key focus.
- →No direct references to equity issuance or new debt fundraising were made during the Q&A or management commentary.
Order book
- →The company has secured around half a million tons of imports for traded products to support Q2 and Q3 up to December (Page 13).
- →Management is focusing on optimizing market requirements by balancing manufactured and imported volumes given supply chain disruptions and raw material costs (Page 14).
- →No explicit orderbook value or pending orders figure was disclosed, but traded volumes are expected to be significantly higher this year compared to last year, indicating robust demand and operational activity (Page 17).
- →The company is progressing with expansion projects including debottlenecking granulation capacity by December and phosphoric acid capacity augmentation by December (Pages 15 and 11).
- →Overall, the company is strategically managing its order execution through a combination of manufacturing and trading to maintain market share amid global disruptions (Pages 13-14, 17).
Capex plans
Yes- →Approved Rs.250 crores investment for setting up an aluminium fluoride plant at Paradeep facility; targeted commissioning within 22-24 months, with expected revenue of Rs.180-200 crores and EBITDA around Rs.50 crores.
- →Phosphoric acid expansion project (phase-I) increasing capacity from 5 lakh tons to 7 lakh tons is on track, with 1 lakh ton expansion expected by December and another 1 lakh ton by next August in FY27.
- →Granulation capacity debottlenecking from 3.7 to 4 lakh tons expected by December FY27; contract awarded and work ongoing.
- →Larger expansion projects worth Rs.3,500-3,600 crores planned for FY29-30, expected in phases by mid FY29-30.
- →Focus on backward integration (e.g., sulphuric acid) to improve supply security and profitability.
- →Strategic intent to diversify into non-subsidy industrial chemicals to build a 20% non-subsidy EBITDA contribution over long term.
How does Paradeep Phosph. rank vs peers in Fertilizers & Agrochemicals?
Pro feature1Paradeep Phosph.
Rev 3Mar 3
See full Fertilizers & Agrochemicals sector rankings
How does Paradeep Phosph. rank in Fertilizers & Agrochemicals?
Compare Paradeep Phosph. against every Fertilizers & Agrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.